# BnH Research co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bnh-research-co

- Industry: Biotechnology
- Headquarters: Goyang, South Korea
- Website: www.bnhresearch.modoo.at/?link=8p6ignhn
- Total disclosed funding: $15M
- Latest round: Series B (Mar 17, 2022)
- Investors on record: 9

## About

BnH Research co.,Ltd. specializes in innovative research and development solutions, focusing on advanced data analytics tools that enhance operational efficiency across various industries such as healthcare, finance, and manufacturing.Founded in 2015, BnH Research co.,Ltd. is headquartered in Goyang, South Korea. The company is led by CEO Seung-soo Chung, who has a background in founding and managing technology-driven ventures. Since its inception, BnH has successfully completed 4 investment deals, with the most recent being in March 2022, where they raised KRW 13 billion in Series B funding from notable investors including CKD Venture Capital and Honest Ventures. There are no mentions of company pivots or subsidiaries.The company's core offerings focus on innovative research and development solutions that enhance various industries. Their main products include advanced data analytics tools designed for both B2B and end-user applications, specifically tailored to solve complex challenges in healthcare, finance, and manufacturing. BnH Research serves a diverse client base, including large enterprises, small to medium-sized businesses, and research institutions across North America, Europe, and Asia, allowing clients to gain strategic advantages through data-driven insights.BnH Research co.,Ltd. generates revenue through a structured model encompassing subscription services, partnerships, and direct sales. Clients typically engage through annual subscription plans that grant access to proprietary software solutions and ongoing support. The company also collaborates with industry leaders on B2B initiatives, further enhancing its market presence. Their pricing plans are aligned with service levels and implementation scales, ensuring comprehensive solutions for operational demands, contributing significantly to the company's financial stability.In March 2022, BnH Research co.,Ltd. raised KRW 13 billion in Series B funding, which will support the development of upcoming products aimed at improving data analytics capabilities. The company plans to expand into new markets, particularly targeting regions in Europe and North America by 2024. The recent funding will facilitate this expansion and enhance product offerings, allowing BnH Research to meet the growing demand for innovative data solutions.

## Funding rounds

- Series B, Mar 17, 2022, $11M — CKD Venture Capital, UTC Investment, LSK Investment, Honest Ventures, We Venture Partners, Medytox Venture Investment, PNP Investment
- Series A, May 29, 2020, $4.5M — UTC Investment, Albatross Investment, KB Securities, LSK Investment, PNP Investment
- Seed, May 1, 2019 — Medytox Venture Investment

## Investors

- Medytox Venture Investment (https://capitalatlas.ai/funds/medytox-venture-investment) — Seed, Series B
- UTC Investment (https://capitalatlas.ai/funds/utc-investment) — Series A, Series B
- Albatross Investment (https://capitalatlas.ai/funds/albatross-investment) — Series A
- KB Securities (https://capitalatlas.ai/funds/kb-securities) — Series A
- LSK Investment (https://capitalatlas.ai/funds/lsk-investment) — Series A, Series B
- PNP Investment (https://capitalatlas.ai/funds/pnp-investment) — Series A, Series B
- CKD Venture Capital (https://capitalatlas.ai/funds/ckd-venture-capital) — Series B
- Honest Ventures (https://capitalatlas.ai/funds/honest-ventures) — Series B
- We Venture Partners (https://capitalatlas.ai/funds/we-venture-partners) — Series B